These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32387789)

  • 1. The association between childhood trauma and treatment outcomes in schizophrenia spectrum disorders.
    Kilian S; Asmal L; Phahladira L; Plessis SD; Luckhoff H; Scheffler F; Buckle C; Emsley R
    Psychiatry Res; 2020 Jul; 289():113004. PubMed ID: 32387789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The history of multiple adverse childhood experiences in patients with schizophrenia is associated with more severe symptomatology and suicidal behavior with gender-specific characteristics.
    Prokopez CR; Vallejos M; Farinola R; Alberio G; Caporusso GB; Cozzarin LG; Chiapella LC; Fuentes P; Daray FM
    Psychiatry Res; 2020 Nov; 293():113411. PubMed ID: 32890864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative Schema and Rumination as Mediators of the Relationship Between Childhood Trauma and Recent Suicidal Ideation in Patients With Early Psychosis.
    Cui Y; Kim SW; Lee BJ; Kim JJ; Yu JC; Lee KY; Won S; Lee SH; Kim SH; Kang SH; Kim E; Piao YH; Kang NI; Chung YC
    J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 30946541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A rare and not very studied disorder: childhood-onset schizophrenia. A case report].
    Bailly D; de Chouly de Lenclave MB
    Encephale; 2004; 30(6):540-7. PubMed ID: 15738856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.
    Pelayo-Terán JM; Diaz FJ; Pérez-Iglesias R; Suárez-Pinilla P; Tabarés-Seisdedos R; de León J; Crespo-Facorro B
    Psychol Med; 2014 Jan; 44(1):37-50. PubMed ID: 23461899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.
    McGregor N; Thompson N; O'Connell KS; Emsley R; van der Merwe L; Warnich L
    Psychiatry Res; 2018 Apr; 262():141-148. PubMed ID: 29448178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Childhood adverse traumatic experiences and schizophrenia].
    Kosteletos I; Kollias K; Stefanis N
    Psychiatriki; 2020; 31(1):23-35. PubMed ID: 32544074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone.
    Nasrallah HA; Duchesne I; Mehnert A; Janagap C; Eerdekens M
    J Clin Psychiatry; 2004 Apr; 65(4):531-6. PubMed ID: 15119916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GWAS analysis of treatment resistant schizophrenia: interaction effect of childhood trauma.
    Koga A; Bani-Fatemi A; Hettige N; Borlido C; Zai C; Strauss J; Gerretsen P; Graff A; Remington G; De Luca V
    Pharmacogenomics; 2017 May; 18(7):663-671. PubMed ID: 28453389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of childhood trauma on sensory gating in patients with first-episode schizophrenia.
    Li XB; Bo QJ; Tian Q; Yang NB; Mao Z; Zheng W; Wen YJ; Wang CY
    BMC Psychiatry; 2018 Aug; 18(1):258. PubMed ID: 30115023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.
    Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Dubreucq J; Faget C; Gabayet F; Honciuc RM; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
    Eur Arch Psychiatry Clin Neurosci; 2019 Jun; 269(4):449-457. PubMed ID: 29396753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1078-85. PubMed ID: 24726579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.